WuXi Biologics acquires first EU drug product facility through Bayer deal
WuXi Biologics will add Bayer’s Leverkusen drug product facility, as part of its continued expansion into the European market.
Archives for January 16, 2020
Commercial manufacture of Bluebird’s gene therapy begins, launched in Germany
Apceth announces that it has started the commercial manufacture of Zyntelgo, after health insurance companies in Germany agree to pricing structure.